| Literature DB >> 25787773 |
Niroshaathevi Arumuggam1, Neil A Bhowmick2, H P Vasantha Rupasinghe1,3.
Abstract
Cancer remains a major health problem worldwide. Among many other factors, two regulatory defects that are present in most cancer cells are constitutive activation of Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway and the induction of indoleamine 2, 3-dioxygenase (IDO), an enzyme that catalyzes tryptophan degradation, through JAK/STAT signaling. Cytokine signaling activates STAT proteins in regulating cell proliferation, differentiation, and survival through modulation of target genes. Many phytochemicals can inhibit both JAK/STAT signaling and IDO expression in antigen-presenting cells by targeting different pathways. Some of the promising phytochemicals that are discussed in this review include resveratrol, cucurbitacin, curcumin, (-)-epigallocatechin gallate, and others. It is now evident that phytochemicals play key roles in inhibition of tumor proliferation and development and provide novel means for therapeutic targeting of cancer.Entities:
Keywords: JAK/STAT; cancer; epigenetics; indoleamine 2, 3-dioxygenase (IDO); phytochemicals
Mesh:
Substances:
Year: 2015 PMID: 25787773 DOI: 10.1002/ptr.5327
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878